Gt Metabolic Solutions, Inc.
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2021-03-03
- Employees
- 1
- Market Cap
- -
- Website
- http://www.gtmetabolic.com
Clinical Trials
10
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Creation of Side-to-Side Compression Anastomosis Using the GT Metabolic Solutions DI Biofragmentable Magnetic Anastomosis System in Mexico
- Conditions
- ObesityType 2 Diabetes
- First Posted Date
- 2025-07-25
- Last Posted Date
- 2025-07-25
- Lead Sponsor
- GT Metabolic Solutions, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT07085741
- Locations
- 🇲🇽
Corporativo Hospital Satelite, Naucalpan de Juarez, Mexico
MagDI U.S. Registry
- Conditions
- Anastomosis, SurgicalInternal HerniaBowel Obstruction
- First Posted Date
- 2025-04-15
- Last Posted Date
- 2025-07-23
- Lead Sponsor
- GT Metabolic Solutions, Inc.
- Target Recruit Count
- 106
- Registration Number
- NCT06928545
- Locations
- 🇺🇸
Baptist Healthcare System, Inc., Louisville, Kentucky, United States
🇺🇸Ochsner Clinic Foundation, Lafayette, Louisiana, United States
🇺🇸Bariatric Specialists of the Carolinas, Cary, North Carolina, United States
Magnetic Duodeno-Ileal Chile Study
- Conditions
- ObesityType 2 Diabetes Mellitus (T2DM)
- First Posted Date
- 2024-09-26
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- GT Metabolic Solutions, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT06613724
- Locations
- 🇨🇱
Clinica MEDS La Dehesa SpA, Santiago, Chile
MagDI Italian Study
- Conditions
- ObesityType 2 Diabetes Mellitus (T2DM)Anastomosis
- First Posted Date
- 2024-09-26
- Last Posted Date
- 2025-07-23
- Lead Sponsor
- GT Metabolic Solutions, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT06613711
- Locations
- 🇮🇹
San Raffaelle Hospital, Milano, Italy
🇮🇹Policlinico San Marco, Bergamo, Italy
🇮🇹Maria Cecilia Hispital, Cotignola, Italy
MagDI Australia Study
- Conditions
- ObesityType 2 Diabetes
- First Posted Date
- 2024-06-25
- Last Posted Date
- 2025-07-23
- Lead Sponsor
- GT Metabolic Solutions, Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT06473831
- Locations
- 🇦🇺
St. John of God Health Care, Inc., Murdoch, Western Australia, Australia
🇦🇺Dr. Mark Magdy (affiliated with St. George Private Hospital), Sydney, New South Wales, Australia
🇦🇺Calvary Health Care Adelaide Limited, Adelaide, Australia
- Prev
- 1
- 2
- Next